PMID: 6405581Jan 1, 1983Paper

Neuroendocrine regulation in depressed postmenopausal women and healthy subjects

Acta Psychiatrica Scandinavica
J D AmsterdamP Snyder

Abstract

Results from prior studies utilizing gonadotropin-releasing hormone (GnRH) in affective illness have been contradictory. There have been no systematic investigations of multiple pituitary hormonal responses to GnRH infusion in either depressed or healthy postmenopausal women. Potential abnormalities in the hypothalamic-pituitary-gonadal (HPG) axis may be limited to postmenopausal women who lack the estradiol feedback influence at the pituitary level. We therefore studied 18 depressed and nine healthy postmenopausal women with the GnRH infusion test and measured LH, FSH, prolactin, growth hormone, and thyrotropin responses. Our findings confirmed earlier reports of a lower basal LH concentration in postmenopausal depressed subjects. GnRH stimulated release of LH, FSH, and prolactin in both patients and controls; however, there were no differences in the mean peak hormone values between groups.

References

Oct 1, 1978·Archives of General Psychiatry·F BrambillaE E Müller
Jan 1, 1977·Acta Obstetricia Et Gynecologica Scandinavica. Supplement·C Lauritzen
May 1, 1979·Psychosomatic Medicine·P G EttigiJ A Seggie
Jun 1, 1978·Archives of General Psychiatry·R L SpitzerE Robins
Nov 1, 1975·The Journal of Clinical Endocrinology and Metabolism·P J SnyderR D Utiger
May 1, 1975·Psychosomatic Medicine·N AltmanS Eto
Nov 11, 1972·Lancet·A J PrangeG R Breese
Mar 1, 1972·Acta Endocrinologica·Y Emment, W P Collins
Nov 1, 1965·The American Journal of Psychiatry·J J Schildkraut
Nov 1, 1969·Archives of General Psychiatry·P S MuellerR K McDonald
Dec 1, 1981·Journal of Affective Disorders·J D AmsterdamP Snyder
Jan 1, 1982·The American Journal of Psychiatry·A WinokurD Brunswick
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Aug 1, 1992·Psychoneuroendocrinology·T F Sadow, R T Rubin
Nov 10, 1998·Biological Psychiatry·H Joffe, L S Cohen
Oct 18, 2002·Psychoneuroendocrinology·P J SchmidtL St Clair
Feb 8, 2003·Psychoneuroendocrinology·I A AntonijevicA Steiger
Jan 14, 2000·Psychoneuroendocrinology·V HendrickS Korenman
Apr 18, 2009·Harvard Review of Psychiatry·Veronica HarshPeter J Schmidt
Oct 8, 1999·Journal of Affective Disorders·J AmsterdamC Beasley
Jul 28, 2004·International Review of Psychiatry·J L Payne
Jan 2, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·R ZanardiE Smeraldi
Nov 13, 2009·Annals of the New York Academy of Sciences·Peter J Schmidt, David R Rubinow
Feb 8, 2005·Psychoneuroendocrinology·Cornelius SchüleRainer Rupprecht
Oct 6, 2016·Comprehensive Psychiatry·R Ramachandran PillaiSoundravally Rajendiran
Dec 1, 1986·The Australian and New Zealand Journal of Psychiatry·A RoyD Pickar
Oct 31, 2002·Human Psychopharmacology·Albert Michael, Veronica O'Keane
Jun 9, 2019·Translational Psychiatry·Daniela StanikovaJulia Sacher
Mar 24, 2020·Acta Pharmacologica Sinica·Wen-Kai BiZhao He

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.